Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

Clinical trial NCT03191149 · RECRUITING

Trial details

NCT number: NCT03191149
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Lung Non-Small Cell Carcinoma Recurrent Lung Non-Small Cell Carcinoma Stage IIIB Lung Non-Small Cell Cancer AJCC v7 Stage IV Lung Non-Small Cell Cancer AJCC v7

Start date: 2018-04-25
Primary completion: 2027-06-30
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.